Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials. - Cooper CL; Morrow G; Yuan M; Postler TS; Neal ML; Cross RW; Woolsey C; Agans KN; Borisevich V; McNamara RP; Atyeo C; Roy V; et al. (EBioMedicine, 2025)